Active — Not RecruitingNot Applicable

PET/MR Versus CECT Scans in Imaging Patients With Ovarian Cancer or Highly Suspected Ovarian Cancer

United States21 participantsStarted 2018-05-12

Plain-language summary

This trial studies how well positron emission tomography/magnetic resonance (PET/MR) versus contrast enhanced computerized tomography (CECT) scans work in locating ovarian cancer tumors in patients with known or suspected ovarian cancer. PET, MR, and CECT scans use different methods to create images of areas inside the body. This trial is being done to see if PET/MR scans may help doctors locate ovarian cancer tumors, predict how well these tumors may be removed during surgery, and predict how patients respond to platinum-based chemotherapies compared to standard of care CECT scans.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with ovarian cancer or highly suspected ovarian cancer who are eligible to undergo laparoscopic evaluation for resectability will be enrolled in the trial. * Patients who have estimated glomerular filtration rate (eGFR) \> 30. Exclusion Criteria: * Patients allergic to gadolinium. * Patients who have eGRF \< 30. * Patients with cardiac pacers. * Pediatric patients. * Greater than 400 pounds in weight. * Blood glucose (\> 200 mg/dl). * Pregnant women.

What they're measuring

Lesion detection accuracy

Timeframe: Up to 3 years

Trial details

NCT IDNCT03965481

SponsorM.D. Anderson Cancer Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-04-30

View on ClinicalTrials.gov More Malignant Ovarian Neoplasm trials